{"id":4335,"date":"2025-10-07T09:35:12","date_gmt":"2025-10-07T06:35:12","guid":{"rendered":"https:\/\/pharmaworlddergi.com\/?p=4335"},"modified":"2025-10-07T09:35:27","modified_gmt":"2025-10-07T06:35:27","slug":"drogsan-ilaclari-50-yilinda-ilk-surdurulebilirlik-raporunu-yayinladi-copy","status":"publish","type":"post","link":"https:\/\/pharmaworlddergi.com\/?p=4335","title":{"rendered":"Drogsan \u0130la\u00e7lar\u0131, 50. Y\u0131l\u0131nda \u0130lk S\u00fcrd\u00fcr\u00fclebilirlik Raporunu Yay\u0131nlad\u0131"},"content":{"rendered":"\n<p><strong>Drogsan \u0130la\u00e7lar\u0131, ikinci 50 y\u0131l\u0131nda k\u00fcresel ve yerel pazardaki pay\u0131n\u0131 art\u0131rmaya odaklan\u0131rken, s\u00fcrd\u00fcr\u00fclebilirlik vizyonunu g\u00fc\u00e7lendirerek \u00e7evresel ve sosyal katk\u0131lara \u00f6ncelik verecek. \u015eirket, \u00fcretim s\u00fcre\u00e7lerinde karbon ve su ayak izini azaltmay\u0131, enerji verimlili\u011fini art\u0131rmay\u0131 ve yenilenebilir enerji yat\u0131r\u0131mlar\u0131n\u0131 hayata ge\u00e7irmeyi hedefliyor. Ayn\u0131 zamanda e\u011fitim, sa\u011fl\u0131k ve toplumsal fayda projeleriyle topluma de\u011fer katmay\u0131 s\u00fcrd\u00fcrecek.<\/strong><\/p>\n\n\n\n<p>T\u00fcrkiye\u2019nin y\u00fczde 100 yerli sermayeli \u00f6nc\u00fc ila\u00e7 \u015firketlerinden Drogsan \u0130la\u00e7lar\u0131, 50. y\u0131l d\u00f6n\u00fcm\u00fcn\u00fc kutlad\u0131\u011f\u0131 bu \u00f6zel y\u0131lda ilk s\u00fcrd\u00fcr\u00fclebilirlik raporunu yay\u0131nlad\u0131. \u015eirket, 2023 y\u0131l\u0131na ait \u00e7evresel, sosyal ve ekonomik performans\u0131n\u0131 kamuoyu ile payla\u015f\u0131rken, ge\u00e7mi\u015fteki ba\u015far\u0131lar\u0131n\u0131 ve gelece\u011fe dair taahh\u00fctlerini de bir arada sundu.<\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"alignleft size-large is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"1017\" src=\"https:\/\/pharmaworlddergi.com\/wp-content\/uploads\/2025\/10\/Dr._Sabri_Oncel1_091906786-1024x1017.jpg\" alt=\"\" class=\"wp-image-4328\" style=\"width:178px;height:auto\" srcset=\"https:\/\/pharmaworlddergi.com\/wp-content\/uploads\/2025\/10\/Dr._Sabri_Oncel1_091906786-1024x1017.jpg 1024w, https:\/\/pharmaworlddergi.com\/wp-content\/uploads\/2025\/10\/Dr._Sabri_Oncel1_091906786-300x298.jpg 300w, https:\/\/pharmaworlddergi.com\/wp-content\/uploads\/2025\/10\/Dr._Sabri_Oncel1_091906786-150x150.jpg 150w, https:\/\/pharmaworlddergi.com\/wp-content\/uploads\/2025\/10\/Dr._Sabri_Oncel1_091906786-768x763.jpg 768w, https:\/\/pharmaworlddergi.com\/wp-content\/uploads\/2025\/10\/Dr._Sabri_Oncel1_091906786-1536x1526.jpg 1536w, https:\/\/pharmaworlddergi.com\/wp-content\/uploads\/2025\/10\/Dr._Sabri_Oncel1_091906786-2048x2034.jpg 2048w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure><\/div>\n\n\n<p>Drogsan \u0130la\u00e7lar\u0131 Genel M\u00fcd\u00fcr Yard\u0131mc\u0131s\u0131 ve S\u00fcrd\u00fcr\u00fclebilirlik Komitesi Ba\u015fkan\u0131 Dr. Sabri \u00d6ncel; <strong><em>\u201cKuruldu\u011fumuz g\u00fcnden bu yana benimsedi\u011fimiz \u2018Sa\u011fl\u0131\u011fa Sayg\u0131\u2019 ilkesi ve s\u00fcrd\u00fcr\u00fclebilirlik stratejimiz do\u011frultusunda hem kurumsal hedeflerimize ula\u015fmay\u0131 hem de t\u00fcm payda\u015flar\u0131m\u0131z\u0131n beklentilerine yan\u0131t vermeyi ama\u00e7l\u0131yoruz. Bug\u00fcne kadar hep topluma, \u00e7evreye ve payda\u015flar\u0131m\u0131za kar\u015f\u0131 sorumluluklar\u0131m\u0131z\u0131 g\u00f6zeterek hareket ettik. Bug\u00fcn s\u00fcrd\u00fcr\u00fclebilirli\u011fi stratejimizin kalbine yerle\u015ftiriyor, sadece finansal performans\u0131m\u0131zla de\u011fil, \u00e7evresel ve sosyal katk\u0131lar\u0131m\u0131zla da de\u011fer yarat\u0131yoruz. Bu rapor, ikinci 50 y\u0131l\u0131m\u0131za daha g\u00fc\u00e7l\u00fc bir ba\u015flang\u0131\u00e7 yapmam\u0131z\u0131 sa\u011flayacak\u201d<\/em><\/strong> dedi.<\/p>\n\n\n\n<p><strong>\u00c7evresel sorumlulukta somut ad\u0131mlar<\/strong><\/p>\n\n\n\n<p><br>Drogsan, iklim de\u011fi\u015fikli\u011fi ve \u00e7evresel risklerle m\u00fccadelede \u00f6nemli ad\u0131mlar att\u0131. 2023 y\u0131l\u0131nda \u00fcretim tesisinin S\u0131f\u0131r At\u0131k Belgesi almas\u0131, karbon ve su ayak izi \u00f6l\u00e7\u00fcm \u00e7al\u0131\u015fmalar\u0131n\u0131n ba\u015flamas\u0131 ve enerji verimlili\u011fini art\u0131rmaya y\u00f6nelik yat\u0131r\u0131mlar \u00f6ne \u00e7\u0131kan uygulamalar aras\u0131nda yer ald\u0131. \u015eirket bu d\u00f6nemde toplam sera gaz\u0131 emisyonunu 30.469 ton CO\u2082e olarak hesaplad\u0131, y\u0131ll\u0131k 64 bin m\u00b3\u2019l\u00fck su ayak izini \u00f6l\u00e7\u00fcmleyerek tasarruf odakl\u0131 projeler geli\u015ftirdi.<\/p>\n\n\n\n<p><strong>\u0130nsana sayg\u0131, topluma katk\u0131<\/strong><\/p>\n\n\n\n<p><br>\u2018\u0130nsana Sayg\u0131\u2019 anlay\u0131\u015f\u0131n\u0131n bir yans\u0131mas\u0131 olarak \u00e7al\u0131\u015fan refah\u0131, i\u015f sa\u011fl\u0131\u011f\u0131 ve g\u00fcvenli\u011fi, f\u0131rsat e\u015fitli\u011fi ve toplumsal katk\u0131 odakl\u0131 uygulamalar\u0131n\u0131 s\u00fcrekli geli\u015ftiren Drogsan, bu kapsamda kad\u0131nlar\u0131n i\u015f hayat\u0131na kat\u0131l\u0131m\u0131n\u0131 ve y\u00f6netim kademelerinde yer almas\u0131n\u0131 \u00f6zellikle destekliyor. Drogsan\u2019da kad\u0131n \u00e7al\u0131\u015fan oran\u0131 y\u00fczde 30, kad\u0131n y\u00f6netici oran\u0131 y\u00fczde 40, \u00fcst d\u00fczey kad\u0131n y\u00f6netici oran\u0131 ise y\u00fczde 54\u2019e ula\u015ft\u0131. \u015eirket, \u00f6n\u00fcm\u00fczdeki d\u00f6nemde Birle\u015fmi\u015f Milletler Kad\u0131n\u0131n G\u00fc\u00e7lenmesi Prensipleri\u2019ne (WEPs) imzac\u0131 olmay\u0131 ve resmi bir Toplumsal Cinsiyet E\u015fitli\u011fi Politikas\u0131 olu\u015fturmay\u0131 hedefliyor.<\/p>\n\n\n\n<p>Toplumsal katk\u0131 alan\u0131nda \u015firket, e\u011fitim, sa\u011fl\u0131k ve sosyal sorumluluk projeleri ba\u015fta olmak \u00fczere topluma de\u011fer katan \u00e7e\u015fitli giri\u015fimler y\u00fcr\u00fct\u00fcyor. T\u00fcrk E\u011fitim Derne\u011fi ile \u201810.000 Gen\u00e7 Me\u015fale Daha Ayd\u0131nl\u0131k T\u00fcrkiye\u2019 kampanyas\u0131na destek verilerek 10 t\u0131p fak\u00fcltesi \u00f6\u011frencisine burs sa\u011flanmas\u0131; \u0130stanbul Maratonu\u2019na kurumsal ko\u015fu tak\u0131m\u0131yla kat\u0131larak maddi imk\u00e2n\u0131 k\u0131s\u0131tl\u0131 \u00f6\u011frencilere burs verilmesi; \u00c7ubuk\u2019taki Fatih Sultan Mehmet Mesleki ve Teknik Anadolu Lisesi\u2019nin robotik tak\u0131m\u0131na sponsor olunarak gen\u00e7lerin bilim ve teknoloji alan\u0131ndaki ba\u015far\u0131lar\u0131n\u0131n desteklenmesi, \u00f6zel gereksinimli bireylere y\u00f6nelik ve sa\u011fl\u0131k alan\u0131nda fark\u0131ndal\u0131k faaliyetleri, Drogsan\u2019\u0131n toplumsal fayda anlam\u0131ndaki \u00f6ne \u00e7\u0131kan \u00e7al\u0131\u015fmalar\u0131 aras\u0131nda yer al\u0131yor.&nbsp;<\/p>\n\n\n\n<p><strong>2035 Vizyonu: S\u00fcrd\u00fcr\u00fclebilir b\u00fcy\u00fcme ve toplumsal katk\u0131<\/strong><\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"alignleft size-large is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"576\" src=\"https:\/\/pharmaworlddergi.com\/wp-content\/uploads\/2025\/10\/Drogsan_Ilaclari_Uretim_Tesisi_Cubuk-Ankara_091908174-1-1024x576.jpg\" alt=\"\" class=\"wp-image-4331\" style=\"width:211px;height:auto\" srcset=\"https:\/\/pharmaworlddergi.com\/wp-content\/uploads\/2025\/10\/Drogsan_Ilaclari_Uretim_Tesisi_Cubuk-Ankara_091908174-1-1024x576.jpg 1024w, https:\/\/pharmaworlddergi.com\/wp-content\/uploads\/2025\/10\/Drogsan_Ilaclari_Uretim_Tesisi_Cubuk-Ankara_091908174-1-300x169.jpg 300w, https:\/\/pharmaworlddergi.com\/wp-content\/uploads\/2025\/10\/Drogsan_Ilaclari_Uretim_Tesisi_Cubuk-Ankara_091908174-1-768x432.jpg 768w, https:\/\/pharmaworlddergi.com\/wp-content\/uploads\/2025\/10\/Drogsan_Ilaclari_Uretim_Tesisi_Cubuk-Ankara_091908174-1-1536x864.jpg 1536w, https:\/\/pharmaworlddergi.com\/wp-content\/uploads\/2025\/10\/Drogsan_Ilaclari_Uretim_Tesisi_Cubuk-Ankara_091908174-1-2048x1152.jpg 2048w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure><\/div>\n\n\n<p>De\u011fi\u015fen d\u00fcnya dinamiklerini ve sa\u011fl\u0131k sekt\u00f6r\u00fcndeki d\u00f6n\u00fc\u015f\u00fcm\u00fc yak\u0131ndan izleyen Drogsan\u2019\u0131n gelece\u011fe y\u00f6nelik hedefleri aras\u0131nda; g\u00fc\u00e7l\u00fc bir \u00fcretim ve Ar-Ge yap\u0131s\u0131yla yerel ve k\u00fcresel pazarda pay\u0131n\u0131 art\u0131rman\u0131n yan\u0131 s\u0131ra s\u00fcrd\u00fcr\u00fclebilirlik, teknolojik yenilik ve nitelikli insan kayna\u011f\u0131na dayal\u0131 bir geli\u015fim de \u00f6ne \u00e7\u0131k\u0131yor. Faaliyetlerinin her a\u015famas\u0131nda \u00e7evresel, sosyal ve y\u00f6neti\u015fim (ESG) performans\u0131n\u0131 geli\u015ftirmeyi ama\u00e7layan \u015firket, gelecek vizyonunu ve s\u00fcrd\u00fcr\u00fclebilirlik stratejisini d\u00f6rt a\u015famal\u0131 bir yol haritas\u0131 ile hayata ge\u00e7iriyor.<\/p>\n\n\n\n<p>Drogsan \u0130la\u00e7lar\u0131 Genel M\u00fcd\u00fcr Yard\u0131mc\u0131s\u0131 ve S\u00fcrd\u00fcr\u00fclebilirlik Komitesi Ba\u015fkan\u0131 Dr. Sabri \u00d6ncel; <strong><em>\u201cGelece\u011fe dair yolculu\u011fumuzda, daha g\u00fc\u00e7l\u00fc bir sa\u011fl\u0131k ekosistemi, daha ya\u015fanabilir bir \u00e7evre ve daha adil bir toplum i\u00e7in kararl\u0131l\u0131kla \u00e7al\u0131\u015fmaya devam edece\u011fiz\u201d<\/em><\/strong> dedi.<\/p>\n\n\n\n<p><strong>Drogsan\u2019\u0131n S\u00fcrd\u00fcr\u00fclebilirlikte \u00d6ne \u00c7\u0131kan Ba\u015far\u0131lar\u0131<\/strong><\/p>\n\n\n\n<ul>\n<li>\u00dcretim tesisine S\u0131f\u0131r At\u0131k Belgesi al\u0131nd\u0131.<\/li>\n\n\n\n<li>Toplam sera gaz\u0131 emisyonu 30.469 ton CO\u2082e olarak \u00f6l\u00e7\u00fcld\u00fc, emisyon ve at\u0131k azalt\u0131m\u0131na y\u00f6nelik \u00e7evre dostu \u00e7\u00f6z\u00fcmler geli\u015ftirmeye y\u00f6nelik \u00e7al\u0131\u015fmalar yap\u0131ld\u0131.<\/li>\n\n\n\n<li>Yenilenebilir enerji yat\u0131r\u0131mlar\u0131n\u0131n fizibilite \u00e7al\u0131\u015fmalar\u0131 ba\u015flat\u0131ld\u0131.<\/li>\n\n\n\n<li>Y\u0131ll\u0131k 64 bin m\u00b3\u2019l\u00fck su ayak izi \u00f6l\u00e7\u00fcmlenerek, tasarruf ve yeniden kullan\u0131m projeleri hayata ge\u00e7irildi.<\/li>\n\n\n\n<li>Kad\u0131n \u00e7al\u0131\u015fan oran\u0131 %30, kad\u0131n y\u00f6netici oran\u0131 %40, \u00fcst d\u00fczey kad\u0131n y\u00f6netici oran\u0131 %54 olarak kaydedildi.<\/li>\n\n\n\n<li>E\u011fitim, sa\u011fl\u0131k ve sosyal sorumluluk projeleri ba\u015fta olmak \u00fczere toplum yarar\u0131na katk\u0131 sa\u011flayan giri\u015fimler y\u00fcr\u00fct\u00fcld\u00fc.<\/li>\n\n\n\n<li>100 milyon kutu kapasiteli yeni tesis yat\u0131r\u0131m\u0131 karar\u0131 ve yumu\u015fak kaps\u00fcl hatt\u0131n\u0131n kurulmas\u0131 ile \u00fcretim altyap\u0131s\u0131 g\u00fc\u00e7lendirildi.<\/li>\n\n\n\n<li>Ar-Ge \u00e7al\u0131\u015fmalar\u0131yla katma de\u011ferli \u00fcr\u00fcnler geli\u015ftirilerek T\u00fcrkiye\u2019nin sa\u011fl\u0131k alan\u0131ndaki d\u0131\u015fa ba\u011f\u0131ml\u0131l\u0131\u011f\u0131 azalt\u0131ld\u0131.<\/li>\n\n\n\n<li>Pazar pay\u0131 her y\u0131l art\u0131r\u0131larak ila\u00e7 sekt\u00f6r\u00fcn\u00fcn \u00fczerinde b\u00fcy\u00fcme sa\u011fland\u0131.<\/li>\n\n\n\n<li>\u0130hracat yap\u0131lan \u00fclke say\u0131s\u0131 ve d\u00f6viz baz\u0131nda ihracat cirosu son 10 y\u0131lda ikiye katland\u0131, ihracat\u0131n ithalat\u0131 kar\u015f\u0131lama oran\u0131nda sekt\u00f6r ortalamas\u0131n\u0131n \u00fczerine \u00e7\u0131k\u0131ld\u0131.<\/li>\n\n\n\n<li>TURQUALITY\u00ae program\u0131na ilk ba\u015fvuruda ve en \u00fcst seviyeden kabul edilerek global \u00f6l\u00e7ekte rekabet g\u00fcc\u00fc art\u0131r\u0131ld\u0131.<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Drogsan \u0130la\u00e7lar\u0131, ikinci 50 y\u0131l\u0131nda k\u00fcresel ve yerel pazardaki pay\u0131n\u0131 art\u0131rmaya odaklan\u0131rken, s\u00fcrd\u00fcr\u00fclebilirlik vizyonunu g\u00fc\u00e7lendirerek \u00e7evresel ve sosyal katk\u0131lara \u00f6ncelik verecek. \u015eirket, \u00fcretim s\u00fcre\u00e7lerinde karbon ve su ayak izini azaltmay\u0131, enerji verimlili\u011fini art\u0131rmay\u0131 ve yenilenebilir enerji yat\u0131r\u0131mlar\u0131n\u0131 hayata ge\u00e7irmeyi hedefliyor. Ayn\u0131 zamanda e\u011fitim, sa\u011fl\u0131k ve toplumsal fayda projeleriyle topluma de\u011fer katmay\u0131 s\u00fcrd\u00fcrecek.<\/p>\n","protected":false},"author":1,"featured_media":4329,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[48,42],"tags":[],"_links":{"self":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts\/4335"}],"collection":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=4335"}],"version-history":[{"count":1,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts\/4335\/revisions"}],"predecessor-version":[{"id":4336,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts\/4335\/revisions\/4336"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/media\/4329"}],"wp:attachment":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=4335"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=4335"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=4335"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}